Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), especially its advanced stage nonalcoholic steatohepatitis (NASH), has become a threatened public health problem worldwide. However, no specific drug has been approved for clinical use to treat patients with NASH, though there are many promising candidates a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue-Kai, Peng, Zong-Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082362/
https://www.ncbi.nlm.nih.gov/pubmed/33935770
http://dx.doi.org/10.3389/fphar.2021.655557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082362/
https://www.ncbi.nlm.nih.gov/pubmed/33935770
http://dx.doi.org/10.3389/fphar.2021.655557

Ejemplares similares